Ads
related to: best medications for brain atrophy and cancer risk- Glioma Treatment Option
Learn More About A Treatment
Option For Your Patients.
- Now Approved
Learn About a Newly Approved
Glioma Treatment Option.
- Access & Resources
Resources Are Available For
You and Your Patients
- FAQ Page
Visit Our FAQ Page To Answer
Your Questions About Treatment.
- Efficacy Information
HCPs, Learn More About The
Efficacy of This Treatment.
- See Press Release
View the Press Release to Learn
A New Glioma Treatment Option.
- Glioma Treatment Option
wiserlifestyles.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...
Non-small cell lung cancer, oesophageal cancer, uterine cervical cancer, head and neck cancer and urothelial cancer: Nephrotoxicity, myelosuppression and nausea and vomiting (30-90%). Oxaliplatin: IV: Reacts with DNA, inducing apoptosis, non-cell cycle specific. Colorectal cancer, oesophageal cancer and gastric cancer
While initially U.S. Food and Drug Administration reviewers expressed concerns about approving the nonbenzodiazepine Z drugs due to concerns of cancer, ultimately they changed their minds and approved the drugs. [65] A 2017 meta-analysis of multiple observational studies found that benzodiazepine use is associated with increased cancer risk. [66]
Past studies report that not getting enough sleep each night can increase a person’s risk for several health concerns, including brain-related conditions, such as cognitive decline and dementia.
In this comprehensive guide, we unveil the 30 best brain supplements meticulously chosen to help adults sharpen their cognitive faculties, improve memory and safeguard against age-related decline ...
The best-studied medical treatment for intracranial hypertension is acetazolamide (Diamox), which acts by inhibiting the enzyme carbonic anhydrase, and it reduces CSF production by six to 57 percent. It can cause the symptoms of hypokalemia (low blood potassium levels), which include muscle weakness and tingling in the fingers.
Ad
related to: best medications for brain atrophy and cancer risk